Unhealthy lifestyle in early psychoses: The role of life stress and the hypothalamic-pituitary-adrenal axis

Psychoneuroendocrinology

Volumn 39, Issue 1, 2014, Pages 1-10

  Manzanares, Núria ^a   Monseny, Rosa ^a   Ortega, Laura ^a   Montalvo, Itziar ^a   Franch, Joan ^a   Gutiérrez Zotes, Alfonso ^a   Reynolds, Rebecca M ^b   Walker, Brian R ^b   Vilella, Elisabet ^a   Labad, Javier ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

At risk mental states; Cortisol; Diet; High risk; Metabolic syndrome; Obesity; Psychoses; Schizophrenia; Stress

Indexed keywords

ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLANZAPINE; PALIPERIDONE; RISPERIDONE; TRIACYLGLYCEROL; SATURATED FATTY ACID;

ADULT; ARTICLE; BODY MASS; CALORIC INTAKE; CARBOHYDRATE INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; FAT INTAKE; FAT MASS; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; HOLMES RAHE SOCIAL READJUSTMENT SCALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAABDOMINAL FAT; LIFE STRESS; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN INTAKE; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SALIVA LEVEL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SMOKING; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD PRESSURE MEASUREMENT; FAMILY HISTORY; HIGH RISK PATIENT; HYPOTHALAMUS HYPOPHYSIS SYSTEM; PSYCHOSIS; RATING SCALE;

AT-RISK MENTAL STATES; CORTISOL; DIET; HIGH RISK; METABOLIC SYNDROME; OBESITY; PSYCHOSES; SCHIZOPHRENIA; STRESS;

ADULT; DIET; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIFE STYLE; MALE; PITUITARY-ADRENAL SYSTEM; PSYCHOTIC DISORDERS; QUESTIONNAIRES; STRESS, PSYCHOLOGICAL;

EID: 84888035889     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.09.023     Document Type: Article

References (41)

1. Aiello G., Horowitz M., Hepgul N., Pariante C.M., Mondelli V. Stress abnormalities in individuals at risk for psychosis: a review of studies in subjects with familial risk or with at risk mental state. Psychoneuroendocrinology 2012, 37:1600-1613.
2. Brown S., Birtwistle J., Roe L., Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol. Med. 1999, 29:697-701.
3. Craig C.L., Marshall A.L., Sjostrom M., Bauman A.E., Booth M.L., Ainsworth B.E., Pratt M., Ekelund U., Yngve A., Sallis J.F., Oja P. International physical activity questionnaire: 12-country reliability and validity. Med. Sci. Sports Exerc. 2003, 35:1381-1395.
4. Dallman M.F., Pecoraro N.C., la Fleur S.E. Chronic stress and comfort foods: self-medication and abdominal obesity. Brain Behav. Immun. 2005, 19:275-280.
5. Dipasquale S., Pariante C.M., Dazzan P., Aguglia E., McGuire P., Mondelli V. The dietary pattern of patients with schizophrenia: a systematic review. J. Psychiatr. Res. 2013, 47:197-207.
6. Epel E., Lapidus R., McEwen B., Brownell K. Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology 2001, 26:37-49.
7. Fabre B., Grosman H., Mazza O., Nolazco C., Machulsky N.F., Mesch V., Schreier L., Gidron Y., Berg G. Relationship between cortisol, life events and metabolic syndrome in men. Stress 2013, 16:16-23.
8. Fusar-Poli P., Borgwardt S., Bechdolf A., Addington J., Riecher-Rossler A., Schultze-Lutter F., Keshavan M., Wood S., Ruhrmann S., Seidman L.J., Valmaggia L., Cannon T., Velthorst E., De Haan L., Cornblatt B., Bonoldi I., Birchwood M., McGlashan T., Carpenter W., McGorry P., Klosterkotter J., McGuire P., Yung A. The psychosis high-risk state: a comprehensive state-of-the-art review. Arch. Gen. Psychiatry 2012, 1-14.
9. Garcia-Prieto M.D., Tebar F.J., Nicolas F., Larque E., Zamora S., Garaulet M. Cortisol secretary pattern and glucocorticoid feedback sensitivity in women from a Mediterranean area: relationship with anthropometric characteristics, dietary intake and plasma fatty acid profile. Clin. Endocrinol. (Oxf.) 2007, 66:185-191.
10. Gardner D.M., Murphy A.L., O'Donnell H., Centorrino F., Baldessarini R.J. International consensus study of antipsychotic dosing. Am. J. Psychiatry 2010, 167:686-693.
11. Gothelf D., Falk B., Singer P., Kairi M., Phillip M., Zigel L., Poraz I., Frishman S., Constantini N., Zalsman G., Weizman A., Apter A. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am. J. Psychiatry 2002, 159:1055-1057.
12. Gozansky W.S., Lynn J.S., Laudenslager M.L., Kohrt W.M. Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic-pituitary-adrenal axis activity. Clin. Endocrinol. (Oxf.) 2005, 63:336-341.
13. Hennekens C.H., Hennekens A.R., Hollar D., Casey D.E. Schizophrenia and increased risks of cardiovascular disease. Am. Heart J. 2005, 150:1115-1121.
14. Holmes T.H., Rahe R.H. The social readjustment rating scale. J. Psychosom. Res. 1967, 11:213-218.
15. Inder W.J., Dimeski G., Russell A. Measurement of salivary cortisol in 2012 - laboratory techniques and clinical indications. Clin. Endocrinol. (Oxf.) 2012, 77:645-651.
16. Johnson R.K., Appel L.J., Brands M., Howard B.V., Lefevre M., Lustig R.H., Sacks F., Steffen L.M., Wylie-Rosett J. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation 2009, 120:1011-1020.
17. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
18. Kirschbaum C., Hellhammer D.H. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 1994, 19:313-333.
19. Kyrou I., Tsigos C. Chronic stress, visceral obesity and gonadal dysfunction. Hormones (Athens) 2008, 7:287-293.
20. Kyrou I., Chrousos G.P., Tsigos C. Stress, visceral obesity, and metabolic complications. Ann. N Y Acad. Sci. 2006, 1083:77-110.
21. Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373:31-41.
22. McEvoy J.P., Meyer J.M., Goff D.C., Nasrallah H.A., Davis S.M., Sullivan L., Meltzer H.Y., Hsiao J., Scott Stroup T., Lieberman J.A. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr. Res. 2005, 80:19-32.
23. McEwen B.S. Stress, adaptation, and disease. Allostasis and allostatic load. Ann. N Y Acad. Sci. 1998, 840:33-44.
24. Oliver G., Wardle J. Perceived effects of stress on food choice. Physiol. Behav. 1999, 66:511-515.
25. Perez-Iglesias R., Crespo-Facorro B., Martinez-Garcia O., Ramirez-Bonilla M.L., Alvarez-Jimenez M., Pelayo-Teran J.M., Garcia-Unzueta M.T., Amado J.A., Vazquez-Barquero J.L. Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naive population. Schizophr. Res. 2008, 99:13-22.
26. Ratliff J.C., Palmese L.B., Reutenauer E.L., Liskov E., Grilo C.M., Tek C. The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study. Compr. Psychiatry 2012, 53:1028-1033.
27. Raune D., Kuipers E., Bebbington P. Stressful and intrusive life events preceding first episode psychosis. Epidemiol. Psichiatr. Soc. 2009, 18:221-228.
28. Reynolds R.M., Walker B.R. Can cortisol predict the future in obesity?. Clin. Endocrinol. (Oxf.) 2007, 67:1-2.
29. Roberts C., Troop N., Connan F., Treasure J., Campbell I.C. The effects of stress on body weight: biological and psychological predictors of change in BMI. Obesity (Silver Spring) 2007, 15:3045-3055.
30. Roca M., Gili M., Garcia-Campayo J., Armengol S., Bauza N., Garcia-Toro M. Stressful life events severity in patients with first and recurrent depressive episodes. Soc. Psychiatry Psychiatr. Epidemiol. 2013, 10.1007/s00127-013-0691-1.
31. Rossler W., Riecher-Rossler A., Angst J., Murray R., Gamma A., Eich D., van Os J., Gross V.A. Psychotic experiences in the general population: a 20-year prospective community study. Schizophr. Res. 2007, 92:1-14.
32. Ryan M.C., Collins P., Thakore J.H. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am. J. Psychiatry 2003, 160:284-289.
33. Ryan M.C., Flanagan S., Kinsella U., Keeling F., Thakore J.H. The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia. Life Sci. 2004, 74:1999-2008.
34. Saha S., Chant D., McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch. Gen. Psychiatry 2007, 64:1123-1131.
35. Shrivastava A., McGorry P.D., Tsuang M., Woods S.W., Cornblatt B.A., Corcoran C., Carpenter W. Attenuated psychotic symptoms syndrome as a risk syndrome of psychosis, diagnosis in DSM-V: the debate. Indian J. Psychiatry 2011, 53:57-65.
36. Thakore J.H., Mann J.N., Vlahos I., Martin A., Reznek R. Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int. J. Obes. Relat. Metab. Disord. 2002, 26:137-141.
37. Treuer T., Hoffmann V.P., Chen A.K., Irimia V., Ocampo M., Wang G., Singh P., Holt S. Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: results from a six-month prospective, multinational, observational study. World J. Biol. Psychiatry 2009, 10:729-740.
38. Tsigos C., Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 2002, 53:865-871.
39. Wardle J., Steptoe A., Oliver G., Lipsey Z. Stress, dietary restraint and food intake. J. Psychosom. Res. 2000, 48:195-202.
40. Wing J.K., Babor T., Brugha T., Burke J., Cooper J.E., Giel R., Jablenski A., Regier D., Sartorius N. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch. Gen. Psychiatry 1990, 47:589-593.
41. Yung A.R., McGorry P.D. Prediction of psychosis: setting the stage. Br. J. Psychiatry Suppl. 2007, 51:s1-s8.